Immuno 2026 Opens with Global Leaders Exploring the Next Decade of Cancer Immunotherapy
Rare Cells, Big Stories: What Circulating Tumor Cells Can Tell Us About Cancer
Global Cancer Leaders Gather in Brussels to Mark 10 Years of World Cancer Research Day
Sjoerd Hubben: A Call to Strengthen Europe’s Pharma Innovation Ecosystem
FDA Approved Lirafugratinib for FGFR2 Fusion or Rearrangement–Positive Cholangiocarcinoma
Mike Bloomberg: Honored to be Reappointed as the WHO Global Ambassador for NCDs and Injuries
Integrated utDNA and ctDNA Testing in Upper Tract Urothelial Carcinoma
Cancer In US Media: 2026
